Nautilus Biotechnology (NAUT) Shares Outstanding (2020 - 2026)

Nautilus Biotechnology has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $127.2 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 0.73% year-over-year to $127.2 million; the TTM figure through Jun 2026 stood at $127.2 million (up 0.73% YoY), while the FY2025 annual figure was $126.5 million, changed 0.29% from the prior year.
• Shares Outstanding (Entity) came in at $127.2 million for Q2 2026 at Nautilus Biotechnology, roughly flat from $127.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $127.2 million in Q2 2026 to a low of $124.5 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $125.6 million, with a median of $125.3 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) soared 548.67% in 2022 and climbed 0.16% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $124.9 million in 2022, then rose by 0.16% to $125.1 million in 2023, then rose by 0.83% to $126.1 million in 2024, then rose by 0.29% to $126.5 million in 2025, then advanced by 0.6% to $127.2 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $127.2 million in Q2 2026, $127.1 million in Q1 2026, and $126.5 million in Q4 2025.